Immediate Impact

1 by Nobel laureates 6 from Science/Nature 64 standout
Sub-graph 1 of 22

Citing Papers

Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023 Standout
Psychedelics reopen the social reward learning critical period
2023 StandoutNature
3 intermediate papers

Works of Abbie Lane being referenced

Early insight predicts depression and attempted suicide after 4 years in first‐episode schizophrenia and schizophreniform disorder
2005
Course of psychopathology, cognition and neurobiological abnormality in schizophrenia: developmental origins and amelioration by antipsychotics?
1998
and 1 more

Author Peers

Author Last Decade Papers Cites
Abbie Lane 1250 243 206 596 404 52 2.0k
C. Larkin 1223 187 181 509 414 46 1.7k
Conall Larkin 1440 270 379 692 444 52 2.3k
Jonna Perälä 1298 149 247 652 262 42 2.5k
Holger J. Sørensen 961 207 240 589 221 76 2.1k
A. Kinsella 1148 128 162 473 443 67 2.0k
Shmuel Fennig 1198 197 177 848 373 76 2.4k
Olesya Ajnakina 994 107 163 443 324 55 1.7k
Ronald O. Rieder 1151 93 379 921 425 34 2.1k
Stephen Cooper 1382 108 474 471 223 83 2.7k
Patrick Miller 1105 178 692 518 265 54 2.3k

All Works

Loading papers...

Rankless by CCL
2026